As Vice President of Marketing for Neurocrine Biosciences, Carol Baum oversees
all commercial operations functions. Carol Baum joined Neurocrine in
2003 as a member of the Marketing Team and has most recently been
responsible for development and implementation of the commercialization
strategy for Indiplon. Prior to joining Neurocrine, Carol was a
Director of Marketing at Aventis Pharmaceuticals and has previous
commercial experience ...
more
Also known as:
- Carol Baum, MBA